135 related articles for article (PubMed ID: 30971293)
21. Elevated level of HSPA1L mRNA correlates with graft-versus-host disease.
Atarod S; Turner B; Pearce KF; Ahmed SS; Norden J; Bogunia-Kubik K; Wang XN; Collin M; Dickinson AM
Transpl Immunol; 2015 Jun; 32(3):188-94. PubMed ID: 25680846
[TBL] [Abstract][Full Text] [Related]
22. Risk Factors for Graft-Versus-Host Disease After Transplantation of Hematopoietic Stem Cells from Unrelated Donors in the China Marrow Donor Program.
Yang F; Lu D; Hu Y; Huang X; Huang H; Chen J; Wu D; Wang J; Wang C; Han M; Chen H
Ann Transplant; 2017 Jun; 22():384-401. PubMed ID: 28652564
[TBL] [Abstract][Full Text] [Related]
23. Real-Time Reflectance Confocal Microscopy of Cutaneous Graft-versus-Host Disease Correlates with Histopathology.
Reingold RE; Monnier J; Ardigò M; Stoll JR; Pena MC; Nanda JK; Dusza SW; Ruiz JD; Flynn L; Afrin A; Klein EG; Prockop SE; Pulitzer MP; Ponce DM; Markova A; Jain M
Transplant Cell Ther; 2022 Jan; 28(1):51.e1-51.e14. PubMed ID: 34571213
[TBL] [Abstract][Full Text] [Related]
24. Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis.
Qayed M; Wang T; Hemmer MT; Spellman S; Arora M; Couriel D; Alousi A; Pidala J; Abdel-Azim H; Aljurf M; Ayas M; Bitan M; Cairo M; Choi SW; Dandoy C; Delgado D; Gale RP; Hale G; Frangoul H; Kamble RT; Kharfan-Dabaja M; Lehman L; Levine J; MacMillan M; Marks DI; Nishihori T; Olsson RF; Hematti P; Ringden O; Saad A; Satwani P; Savani BN; Schultz KR; Seo S; Shenoy S; Waller EK; Yu L; Horowitz MM; Horan J
Biol Blood Marrow Transplant; 2018 Mar; 24(3):521-528. PubMed ID: 29155316
[TBL] [Abstract][Full Text] [Related]
25. Chronic cutaneous graft-versus-host disease in children: A report of 14 patients from a tertiary care pediatric dermatology clinic.
Nanda A; Husain MAA; Al-Herz W; Almekaimi A; Al-Sabah H; Al-Otaibi M
Pediatr Dermatol; 2018 May; 35(3):343-353. PubMed ID: 29536565
[TBL] [Abstract][Full Text] [Related]
26. Histologic diagnosis and grading of esophageal acute graft-versus-host disease.
Kreft A; Neumann H; von Bach DS; Wagner-Drouet EM
Virchows Arch; 2019 Mar; 474(3):325-332. PubMed ID: 30607554
[TBL] [Abstract][Full Text] [Related]
27. Extracorporeal photopheresis in 62 patients with acute and chronic GVHD: results of treatment with the COBE Spectra System.
Hautmann AH; Wolff D; Hahn J; Edinger M; Schirmer N; Ammer J; Holler B; Landfried K; Hautmann MG; Ahrens N; Ugocsai P; Andreesen R; Holler E
Bone Marrow Transplant; 2013 Mar; 48(3):439-45. PubMed ID: 22922407
[TBL] [Abstract][Full Text] [Related]
28. Dendritic cell chimerism in oral mucosa of transplanted patients affected by graft-versus-host disease.
Pérez CA; Rabanales R; Rojas-Alcayaga G; Larrondo M; Escobar AF; López MN; Salazar-Onfray F; Alfaro JI; González FE
J Oral Pathol Med; 2016 Feb; 45(2):127-35. PubMed ID: 26102283
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathologic characteristics of cutaneous chronic graft-versus-host diseases: a retrospective study in Korean patients.
Kim SJ; Choi JM; Kim JE; Cho BK; Kim DW; Park HJ
Int J Dermatol; 2010 Dec; 49(12):1386-92. PubMed ID: 21155089
[TBL] [Abstract][Full Text] [Related]
30. Graft-versus-host disease prophylaxis with tacrolimus and mycophenolate mofetil in HLA-matched nonmyeloablative transplant recipients is associated with very low incidence of GVHD and nonrelapse mortality.
Sabry W; Le Blanc R; Labbé AC; Sauvageau G; Couban S; Kiss T; Busque L; Cohen S; Lachance S; Roy DC; Roy J
Biol Blood Marrow Transplant; 2009 Aug; 15(8):919-29. PubMed ID: 19589481
[TBL] [Abstract][Full Text] [Related]
31. Round-Robin test for the histological diagnosis of acute colonic Graft-versus-Host disease validating established histological criteria and grading systems.
Hippe K; Kreft A; Reu-Hofer S; Rosenwald A; Ferrazzi F; Daniel C; Amann K; Kraus S; Holler E; Kandulski A; Hirsch D; Buttner A; Rösler W; Hildner K; Winkler J; Büttner-Herold M
Virchows Arch; 2023 Jul; 483(1):47-58. PubMed ID: 37165134
[TBL] [Abstract][Full Text] [Related]
32. Chronic intestinal graft-versus-host disease: clinical, histological and immunohistochemical analysis of 17 children.
Patey-Mariaud de Serre N; Reijasse D; Verkarre V; Canioni D; Colomb V; Haddad E; Brousse N
Bone Marrow Transplant; 2002 Feb; 29(3):223-30. PubMed ID: 11859394
[TBL] [Abstract][Full Text] [Related]
33. Early onset of acute GVHD indicates worse outcome in terms of severity of chronic GVHD compared with late onset.
Moon JH; Kim SN; Kang BW; Chae YS; Kim JG; Ahn JS; Kim YK; Yang DH; Lee JJ; Kim HJ; Choi YJ; Shin HJ; Chung JS; Cho GJ; Sohn SK
Bone Marrow Transplant; 2010 Oct; 45(10):1540-5. PubMed ID: 20190848
[TBL] [Abstract][Full Text] [Related]
34. A reappraisal of the histopathologic criteria for the diagnosis of cutaneous allogeneic acute graft-vs-host disease.
Massi D; Franchi A; Pimpinelli N; Laszlo D; Bosi A; Santucci M
Am J Clin Pathol; 1999 Dec; 112(6):791-800. PubMed ID: 10587702
[TBL] [Abstract][Full Text] [Related]
35. Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients.
Perotti C; Del Fante C; Tinelli C; Viarengo G; Scudeller L; Zecca M; Locatelli F; Salvaneschi L
Transfusion; 2010 Jun; 50(6):1359-69. PubMed ID: 20113452
[TBL] [Abstract][Full Text] [Related]
36. Survival and graft versus host disease in first 100 patients undergoing allogeneic peripheral blood stem cell transplantation: a single centre experience.
Shamsi TS; Irfan M; Farzana T; Ansari SH; Panjwani VK; Taj M; Ahmad G; Shakoor N; Baig MI
J Pak Med Assoc; 2005 Nov; 55(11):469-75. PubMed ID: 16304864
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of skin histology in GVHD after intestinal transplantation.
Pintar T; Zorc-Pleskovic R; Alessiani M; Milutinović A; Pleskovic A
Eur J Pediatr Surg; 2007 Dec; 17(6):412-5. PubMed ID: 18072027
[TBL] [Abstract][Full Text] [Related]
38. Dermatologic treatment of cutaneous graft versus host disease.
Peñas PF; Fernández-Herrera J; García-Diez A
Am J Clin Dermatol; 2004; 5(6):403-16. PubMed ID: 15663337
[TBL] [Abstract][Full Text] [Related]
39. Photochemotherapy of Cutaneous Graft-versus-Host Disease May Reduce Concomitant Visceral Disease.
Feldreich N; Ringden O; Emtestam L; Omazic B
Dermatology; 2016; 232(4):453-63. PubMed ID: 27433980
[TBL] [Abstract][Full Text] [Related]
40. Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting.
Afram G; Simón JAP; Remberger M; Caballero-Velázquez T; Martino R; Piñana JL; Ringden O; Esquirol A; Lopez-Corral L; Garcia I; López-Godino O; Sierra J; Caballero D; Ljungman P; Vazquez L; Hägglund H
Med Oncol; 2018 Apr; 35(6):79. PubMed ID: 29696461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
